NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, today announced a key milestone in their partnership to develop new analysis tools to accelerate research on NanoString’s nCounter® Analysis System. After successful completion of an Early Access Program announced in May, the parties are expanding access to new analysis capabilities to all nCounter users. The new analysis functionality is built into ROSALIND®, OnRamp’s cloud-based analysis platform that facilitates data visualization, exploration and collaboration. NanoString will support ROSALIND as a preferred analysis solution for nCounter data and make it broadly available to users of the nCounter Analysis System.
Search
Recent Posts
See AllBy: Rebecca Torrence The Centers for Medicare & Medicaid Services (CMS) will fund four states to expand telehealth and other healthcare services in their rural communities. Four organizations are set
CarDon & Associates turned to Third Eye Health for a telehealth solution. The telehealth technology offered fast connectivity with access to board-certified, state-licensed physicians who are trained
By: Kayla Blanton Since the onset of the pandemic, demand for therapy and mental health services has skyrocketed. According to a November 2020 poll from the American Psychological Association (APA), 7